1. Vorselaars, VMM, Hosman, AE, Westermann, CJJ, et al . Pulmonary arterial hypertension and hereditary haemorrhagic telangiectasia. Int J Mol Sci 2018; 19: 3203.
Google Scholar | Crossref | Medline2. Germain, M, Eyries, M, Montani, D, et al. Genome-wide association analysis identifies a susceptibility locus for pulmonary arterial hypertension. Nat Genet 2013; 45: 518–521.
Google Scholar | Crossref | Medline | ISI3. Cheng, XS, Guo, YH, He, JG, et al . Analysis on inpatient pulmonary hypertension surveillance in Fuwai Cardiovascular Hospital from 1996 to 2005. Zhonghua Xin Xue Guan Bing Za Zhi 2007; 35: 251–254.
Google Scholar | Medline4. Benza, RL, Miller, DP, Barst, RJ, et al. An evaluation of long-term survival from time of diagnosis in pulmonary arterial hypertension from the REVEAL Registry. Chest 2012; 142: 448–456.
Google Scholar | Crossref | Medline | ISI5. Gore, B, Izikki, M, Mercier, O, et al. Key role of the endothelial TGF-β/ALK1/endoglin signaling pathway in humans and rodents pulmonary hypertension. PLoS One 2014; 9: e100310.
Google Scholar | Crossref | Medline6. Girerd, B, Montani, D, Coulet, F, et al. Clinical outcomes of pulmonary arterial hypertension in patients carrying an ACVRL1 (ALK1) mutation. Am J Respir Crit Care Med 2010; 181: 851–861.
Google Scholar | Crossref | Medline | ISI7. Brenner, L, Chung, WK. Clinical and molecular genetic features of hereditary pulmonary arterial hypertension. Compr Physiol 2011; 1: 1721–1728.
Google Scholar | Crossref | Medline | ISI8. Simonneau, G, Gatzoulis, MA, Adatia, I, et al. Updated clinical classification of pulmonary hypertension. J Am Coll Cardiol 2013; 62: D34–D41.
Google Scholar | Crossref | Medline | ISI9. Humbert, M, Ghofrani, HA. The molecular targets of approved treatments for pulmonary arterial hypertension. Thorax 2016; 71: 73–83.
Google Scholar | Crossref | Medline | ISI10. Zhao, Y, Zhang, Y, Wang, X, et al. Variant analysis in Chinese families with hereditary hemorrhagic telangiectasia. Mol Genet Genomic Med 2019; 7: e893.
Google Scholar | Crossref | Medline11. Chen, YJ, Yang, QH, Liu, D, et al. Clinical and genetic characteristics of Chinese patients with hereditary haemorrhagic telangiectasia-associated pulmonary hypertension. Eur J Clin Invest 2013; 43: 1016–1024.
Google Scholar | Crossref | Medline12. Galie, N, Humbert, M, Vachiery, JL, et al. 2015 ESC/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension: The Joint Task Force for the Diagnosis and Treatment of Pulmonary Hypertension of the European Society of Cardiology (ESC) and the European Respiratory Society (ERS): Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC), International Society for Heart and Lung Transplantation (ISHLT). Eur Heart J 2016; 37: 67–119.
Google Scholar | Crossref | Medline | ISI13. Bossone, E, D'Andrea, A, D'Alto, M, et al. Echocardiography in pulmonary arterial hypertension: from diagnosis to prognosis. J Am Soc Echocardiogr 2013; 26: 1–14.
Google Scholar | Crossref | Medline | ISI14. Shovlin, CL, Guttmacher, AE, Buscarini, E, et al. Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet 2000; 91: 66–67.
Google Scholar | Crossref | Medline | ISI15. Baumgartner, H, De Backer, J, Babu-Narayan, SV, et al. 2020 ESC Guidelines for the management of adult congenital heart disease. Eur Heart J 2021; 42: 563–645.
Google Scholar | Crossref | Medline16. Sitbon, O, Humbert, M, Jaïs, X, et al. Long-term response to calcium channel blockers in idiopathic pulmonary arterial hypertension. Circulation 2005; 111: 3105–3111.
Google Scholar | Crossref | Medline | ISI17. Douwes, JM, Humpl, T, Bonnet, D, et al. Acute vasodilator response in pediatric pulmonary arterial hypertension: current clinical practice from the TOPP registry. J Am Coll Cardiol 2016; 67: 1312–1323.
Google Scholar | Crossref | Medline18. Liu, X, Jiang, T, Piao, C, et al. Screening mutations of MYBPC3 in 114 unrelated patients with hypertrophic cardiomyopathy by targeted capture and next-generation sequencing. Sci Rep 2015; 5: 11411.
Google Scholar19. Abdalla, SA, Letarte, M. Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease. J Med Genet 2006; 43: 97–110.
Google Scholar | Crossref | Medline | ISI20. Badesch, DB, Raskob, GE, Elliott, CG, et al. Pulmonary arterial hypertension: baseline characteristics from the REVEAL Registry. Chest 2010; 137: 376–387.
Google Scholar | Crossref | Medline | ISI21. Fujiwara, M, Yagi, H, Matsuoka, R, et al. Implications of mutations of activin receptor-like kinase 1 gene (ALK1) in addition to bone morphogenetic protein receptor II gene (BMPR2) in children with pulmonary arterial hypertension. Circ J 2008; 72: 127–133.
Google Scholar | Crossref | Medline22. Machado, RD, James, V, Southwood, M, et al. Investigation of second genetic hits at the BMPR2 locus as a modulator of disease progression in familial pulmonary arterial hypertension. Circulation 2005; 111: 607–613.
Google Scholar | Crossref | Medline23. Tørring, PM, Brusgaard, K, Ousager, LB, et al. National mutation study among Danish patients with hereditary haemorrhagic telangiectasia. Clin Genet. 2014; 86: 123–133.
Google Scholar | Crossref | Medline24. Attisano, L, Cárcamo, J, Ventura, F, et al. Identification of human activin and TGF beta type I receptors that form heteromeric kinase complexes with type II receptors. Cell 1993; 75: 671–680.
Google Scholar | Crossref | Medline | ISI25. Machado, RD, Southgate, L, Eichstaedt, CA, et al. Pulmonary arterial hypertension: a current perspective on established and emerging molecular genetic defects. Hum Mutat 2015; 36: 1113–1127.
Google Scholar | Crossref | Medline | ISI26. Canzonieri, C, Centenara, L, Ornati, F, et al. Endoscopic evaluation of gastrointestinal tract in patients with hereditary hemorrhagic telangiectasia and correlation with their genotypes. Genet Med 2014; 16: 3–10.
Google Scholar | Crossref | Medline27. Brakensiek, K, Frye-Boukhriss, H, Mälzer, M, et al. Detection of a significant association between mutations in the ACVRL1 gene and hepatic involvement in German patients with hereditary haemorrhagic telangiectasia. Clin Genet. 2008; 74: 171–177.
Google Scholar | Crossref | Medline28. Pfarr, N, Fischer, C, Ehlken, N, et al. Hemodynamic and genetic analysis in children with idiopathic, heritable, and congenital heart disease associated pulmonary arterial hypertension. Respir Res 2013; 14: 3.
Google Scholar | Crossref | Medline29. Chida, A, Shintani, M, Yagi, H, et al. Outcomes of childhood pulmonary arterial hypertension in BMPR2 and ALK1 mutation carriers. Am J Cardiol 2012; 110: 586–593.
Google Scholar | Crossref | Medline